Ark, a Singapore-based medtech enterprise focused on early cancer detection, has raised a record US$ 40 million in Series A funding. Ark’s vision is “a world without late-stage cancer” and its mission is to eliminate late-stage cancer related death by 2048 through the introduction of accurate, affordable, and actionable cancer detection technologies. This record-breaking Series… Read More »
The Food and Drug Administration is blessing a public database for use by genetic test developers that are submitting premarket submissions. The agency says the database is recognized as a source of valid scientific evidence that now can be used by developers of genetic tests to support clinical validity in premarket submissions to the agency.… Read More »
December 05, 2018 Share this content: Participants who received sertraline did experience greater improvements in global quality of life scores. Individuals with chronic breathlessness who were treated with 25 to 100 mg sertraline for 4 weeks showed no improvement in symptomatic relief compared with placebo, according to study results published in the European Respiratory Journal.… Read More »
Nearly half of Medicare patients in long-term care hospitals experienced adverse or temporary harm events during their stays. That’s among the findings of the HHS Office of Inspector General, which conducted a two-stage medical record review using physician reviewers to identify adverse events and temporary harm events in the sampled records. One in five Medicare… Read More »